Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health ...
(RTTNews) - Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, on Monday, provided an update on a biomarker analysis from its phase II SHINE study of CT1812in ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from ...
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results